Substance
ID:184672
Names and Identifiers
Synonyms
3β,5,14,19-Tetrahydroxy-5β,20(22)-cardenolideK-StrophanthidolStrophanthidol5β,20(22)-Cardenolide-3β,5,14,19-tetrol
IUPAC name
4-[5,7,11-trihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]-2,5-dihydrofuran-2-one
IUPAC Traditional name
4-[5,7,11-trihydroxy-2-(hydroxymethyl)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]-5H-furan-2-one
Properties
Safety Information
GHS Precautionary statements
P261-P280-P301+P310-P311
RID/ADR
UN 2811 6.1/PG 3
Safety Statements
45
German water hazard class
3
RTECS
FH5325000
GHS Signal Word
Danger
Packing Group
3
GHS Hazard statements
H301-H311-H331
Risk Statements
23/24/25
UN Number
2811
European Hazard Symbols
Toxic (T)GHS Pictograms
Acute toxicity (oral, dermal, inhalation), categories 1,2,3
Personal Protective Equipment
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Class
6.1
Molecule Details
General description
Reduced aglycone of K-strophanthin and cymarin, one of the primary excretion products after use of the glycosides in treatment of congestive heart failure.1
Reduced aglycone of K-strophanthin and cymarin, one of the primary excretion products after use of the glycosides in treatment of congestive heart failure.1
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data